Cargando…

The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial

BACKGROUND: The Multidomain Alzheimer Preventive Trial (MAPT) was designed to assess the efficacy of omega-3 fatty acid supplementation, multidomain intervention (MI), or a combination of both on cognition. Although the MAPT study was negative, an effect of MI in maintaining cognitive functions comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delrieu, Julien, Voisin, Thierry, Saint-Aubert, Laure, Carrie, Isabelle, Cantet, Christelle, Vellas, Bruno, Payoux, Pierre, Andrieu, Sandrine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574215/ https://www.ncbi.nlm.nih.gov/pubmed/33076983 http://dx.doi.org/10.1186/s13195-020-00683-6

Ejemplares similares

Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial
por: Delrieu, Julien, et al.
Publicado: (2023)

Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT)
por: Rolland, Yves, et al.
Publicado: (2019)

Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study
por: Guerrier, Laura, et al.
Publicado: (2019)

Excessive Sleepiness and Longer Nighttime in Bed Increase the Risk of Cognitive Decline in Frail Elderly Subjects: The MAPT-Sleep Study
por: Gabelle, Audrey, et al.
Publicado: (2017)

Understanding the Complexities of Functional Ability in Alzheimer’s Disease: More Than Just Basic and Instrumental Factors
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
por: Nourhashemi, Fati, et al.
Publicado: (2018)

Impact of multidomain preventive strategies on functional brain connectivity in older adults with cognitive complaint: Subset from the Montpellier center of the ancillary MAPT-MRI study
por: Perus, Lisa, et al.
Publicado: (2023)

Effectiveness of a specific care plan in patients with Alzheimer’s disease: cluster randomised trial (PLASA study)
por: Nourhashemi, Fati, et al.
Publicado: (2010)

Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study
por: Planton, Mélanie, et al.
Publicado: (2020)

Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia
por: Hooper, Claudie, et al.
Publicado: (2017)

Regulation of human MAPT gene expression
por: Caillet-Boudin, Marie-Laure, et al.
Publicado: (2015)

Should interventions to treat or prevent Alzheimer’s disease be tested in a population or as targeted treatment of highly selected study participants?
por: Ousset, Pierre Jean, et al.
Publicado: (2013)

Potentially Inappropriate Medication Prescribing Detected by Computer Algorithm among Older Patients: Results from the MAPT Study
por: Pagès, Arnaud, et al.
Publicado: (2021)

Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer
por: Bailly, Matthieu, et al.
Publicado: (2015)

A 1‐year randomized controlled trial of a nutritional blend to improve nutritional biomarkers and prevent cognitive decline among community‐dwelling older adults: The Nolan Study
por: Giudici, Kelly V., et al.
Publicado: (2022)

Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo
por: Saint-Aubert, L., et al.
Publicado: (2013)

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
por: Tauber, Christina V., et al.
Publicado: (2023)

[(18)F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers
por: Wolters, Emma E., et al.
Publicado: (2021)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

[(18)F]AV‐1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
por: Bevan Jones, W. Richard, et al.
Publicado: (2016)

Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013)

Absence of Relationship Between Self-Reported Sleep Measures and Amyloid Load in Elderly Subjects
por: Gabelle, Audrey, et al.
Publicado: (2019)

Ancillary mathematics
por: Massey, Harrie Stewart Wilson, et al.
Publicado: (1959)

Cross-sectional associations between cortical thickness and physical activity in older adults with spontaneous memory complaints: The MAPT Study
por: Raffin, Jérémy, et al.
Publicado: (2023)

Cerebral FDG-PET scanning abnormalities in optimally treated HIV patients
por: Andersen, Åse B, et al.
Publicado: (2010)

Diagnostic accuracy of cerebral [(18)F]FDG PET in atypical parkinsonism
por: Houssein, Naba Jawad, et al.
Publicado: (2023)

Cerebral Oxygenation During Neonatal Intubation–Ancillary Study of the Prettineo–Study
por: Vedrenne-Cloquet, Meryl, et al.
Publicado: (2019)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas
por: Dequanter, D, et al.
Publicado: (2015)

Predictors of decline in walking ability in community-dwelling Alzheimer’s disease patients: Results from the 4-years prospective REAL.FR study
por: Rolland, Yves, et al.
Publicado: (2013)

Tau PET imaging: present and future directions
por: Saint-Aubert, Laure, et al.
Publicado: (2017)

(18)F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
por: Smith, Ruben, et al.
Publicado: (2016)

Ancillary investigations in uveitis
por: Gupta, Vishali, et al.
Publicado: (2013)

MAPT association with REM sleep behavior disorder
por: Fernández-Santiago, Rubén, et al.
Publicado: (2017)

What’s in a Gene? The Outstanding Diversity of MAPT
por: Ruiz-Gabarre, Daniel, et al.
Publicado: (2022)

Mitochondrial Defects in Fibroblasts of Pathogenic MAPT Patients
por: Bharat, Vinita, et al.
Publicado: (2021)

Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial
por: Coley, Nicola, et al.
Publicado: (2021)

Body Weight Variation Patterns as Predictors of Cognitive Decline over a 5 Year Follow-Up among Community-Dwelling Elderly (MAPT Study)
por: Giudici, Kelly Virecoulon, et al.
Publicado: (2019)

Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease
por: Coupland, Kirsten G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_06asttrvm8av4bjvk29ivqqvsv